Assembly Biosciences, Inc.
(NASDAQ : ASMB)

( )
ASMB After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-1.00%171.250.4%$136.39m
JAZZJazz Pharmaceuticals Plc
-0.35%176.492.2%$114.93m
SAGESAGE Therapeutics, Inc.
-0.04%168.569.6%$110.81m
PRGOPerrigo Co. Plc
0.16%75.956.7%$91.16m
ENDPEndo International Plc
-0.62%11.158.9%$71.94m
MNKMallinckrodt Plc
-1.03%21.6821.1%$69.05m
ICPTIntercept Pharmaceuticals, Inc.
-2.02%93.8021.8%$66.13m
ZGNXZogenix, Inc.
-0.93%58.4011.9%$66.12m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.61%146.226.8%$62.62m
CTLTCatalent Inc
1.48%43.982.6%$61.16m
MDCOMedicines Company
-0.70%39.8021.8%$38.54m
UTHRUnited Therapeutics Corporation
0.76%125.0314.4%$38.37m
SUPNSupernus Pharmaceuticals, Inc.
1.15%54.886.3%$36.47m
PTLAPortola Pharmaceuticals, Inc.
0.05%39.947.7%$34.31m
ICLRICON Plc
1.29%140.144.2%$31.48m

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.